SI9720060B - Use of 2-phenyl-1, 2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease - Google Patents
Use of 2-phenyl-1, 2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease Download PDFInfo
- Publication number
- SI9720060B SI9720060B SI9720060A SI9720060A SI9720060B SI 9720060 B SI9720060 B SI 9720060B SI 9720060 A SI9720060 A SI 9720060A SI 9720060 A SI9720060 A SI 9720060A SI 9720060 B SI9720060 B SI 9720060B
- Authority
- SI
- Slovenia
- Prior art keywords
- alzheimer
- phenyl
- treatment
- pharmaceutical preparation
- benzisoselenazol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22551296 | 1996-08-27 | ||
| PCT/DE1997/000701 WO1998008511A1 (de) | 1996-08-27 | 1997-04-07 | Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-one zur herstellung einer pharmazeutischen zubereitung für die behandlung der alzheimer-krankheit |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SI9720060A SI9720060A (sl) | 1999-06-30 |
| SI9720060B true SI9720060B (en) | 2001-12-31 |
Family
ID=16830487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9720060A SI9720060B (en) | 1996-08-27 | 1997-04-07 | Use of 2-phenyl-1, 2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5948800A (zh) |
| EP (1) | EP0826370B1 (zh) |
| KR (1) | KR20000035859A (zh) |
| CN (1) | CN1112922C (zh) |
| AT (1) | ATE219361T1 (zh) |
| AU (2) | AU3866997A (zh) |
| BR (1) | BR9711259A (zh) |
| CA (1) | CA2213794C (zh) |
| CZ (1) | CZ295364B6 (zh) |
| DE (2) | DE59707550D1 (zh) |
| DK (1) | DK0826370T3 (zh) |
| EE (1) | EE03953B1 (zh) |
| ES (1) | ES2177849T3 (zh) |
| FI (1) | FI119622B (zh) |
| HK (1) | HK1020317A1 (zh) |
| HU (1) | HU225264B1 (zh) |
| IL (1) | IL127113A (zh) |
| LT (1) | LT4602B (zh) |
| LV (1) | LV12251B (zh) |
| NO (1) | NO312812B1 (zh) |
| NZ (1) | NZ332292A (zh) |
| PL (1) | PL188481B1 (zh) |
| PT (1) | PT826370E (zh) |
| SI (1) | SI9720060B (zh) |
| TR (1) | TR199700858A2 (zh) |
| TW (1) | TW501925B (zh) |
| UA (1) | UA59367C2 (zh) |
| WO (2) | WO1998008511A1 (zh) |
| ZA (1) | ZA977644B (zh) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0729756T3 (da) * | 1993-10-27 | 2000-06-05 | Daiichi Seiyaku Co | Granulært farmaceutisk præparat |
| JP2000016935A (ja) * | 1998-07-01 | 2000-01-18 | Dai Ichi Seiyaku Co Ltd | シクロオキシゲナーゼ阻害剤 |
| CA2368484A1 (en) | 1999-03-31 | 2000-10-05 | Daiichi Pharmaceutical Co., Ltd. | Substrates for thioredoxin reductase |
| WO2003010154A1 (en) * | 2001-07-26 | 2003-02-06 | Samsung Electronics Co. Ltd. | Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses |
| WO2003010143A1 (en) | 2001-07-26 | 2003-02-06 | Samsung Electronics Co., Ltd. | Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| WO2003010153A1 (en) | 2001-07-26 | 2003-02-06 | Samsung Electronics Co. Ltd. | N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses |
| GB201102248D0 (en) | 2011-02-09 | 2011-03-23 | Isis Innovation | Treatment of bipolar disorder |
| CN103965188A (zh) * | 2013-01-29 | 2014-08-06 | 中山大学 | 含硒多奈哌齐类似物 |
| EP2950102A1 (en) | 2014-05-30 | 2015-12-02 | Biocross, S.L. | Method for the diagnosis of alzheimer s disease and mild cognitive impairment |
| US10058542B1 (en) | 2014-09-12 | 2018-08-28 | Thioredoxin Systems Ab | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith |
| EP3067699A1 (en) | 2015-03-11 | 2016-09-14 | Neuron Bio, S.A. | Method for diagnosing alzheimer's disease |
| PL237739B1 (pl) | 2018-06-06 | 2021-05-17 | Univ Gdanski | Genisteina do zastosowania do leczenia choroby Alzheimera |
| CN113116888B (zh) * | 2021-04-19 | 2022-08-26 | 上海兴糖生物技术有限公司 | 依布硒啉的用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3616923A1 (de) * | 1986-05-20 | 1987-11-26 | Nattermann A & Cie | Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on |
| DE3638124C2 (de) * | 1986-11-08 | 1996-09-05 | Nattermann A & Cie | Neue pharmazeutische Verwendung von Ebselen |
| JPH01131113A (ja) * | 1987-08-27 | 1989-05-24 | Dai Ichi Seiyaku Co Ltd | 脳障害治療剤 |
| JPH0238591A (ja) | 1988-07-27 | 1990-02-07 | Fujikura Ltd | 高純度銅の製造方法 |
| US5385726A (en) * | 1990-08-06 | 1995-01-31 | Rhone-Poulenc Rorer Gmbh | Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one |
| DE4024885C2 (de) * | 1990-08-06 | 2002-07-18 | Nattermann A & Cie | Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on |
| FR2669633B1 (fr) * | 1990-11-23 | 1993-01-22 | Adir | Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| JPH07233056A (ja) * | 1993-09-03 | 1995-09-05 | Dai Ichi Seiyaku Co Ltd | リポキシゲナーゼ阻害剤 |
-
1997
- 1997-03-17 AT AT97104503T patent/ATE219361T1/de not_active IP Right Cessation
- 1997-03-17 ES ES97104503T patent/ES2177849T3/es not_active Expired - Lifetime
- 1997-03-17 DK DK97104503T patent/DK0826370T3/da active
- 1997-03-17 EP EP97104503A patent/EP0826370B1/de not_active Expired - Lifetime
- 1997-03-17 PT PT97104503T patent/PT826370E/pt unknown
- 1997-03-17 DE DE59707550T patent/DE59707550D1/de not_active Expired - Fee Related
- 1997-04-07 WO PCT/DE1997/000701 patent/WO1998008511A1/de active IP Right Grant
- 1997-04-07 NZ NZ332292A patent/NZ332292A/en unknown
- 1997-04-07 SI SI9720060A patent/SI9720060B/sl not_active IP Right Cessation
- 1997-04-07 CN CN97195890A patent/CN1112922C/zh not_active Expired - Fee Related
- 1997-04-07 BR BR9711259A patent/BR9711259A/pt not_active Application Discontinuation
- 1997-04-07 IL IL12711397A patent/IL127113A/xx not_active IP Right Cessation
- 1997-04-07 CZ CZ1999317A patent/CZ295364B6/cs not_active IP Right Cessation
- 1997-04-07 HU HU9903213A patent/HU225264B1/hu not_active IP Right Cessation
- 1997-04-07 EE EEP199900007A patent/EE03953B1/xx not_active IP Right Cessation
- 1997-07-04 UA UA99010526A patent/UA59367C2/uk unknown
- 1997-08-04 DE DE19733690A patent/DE19733690A1/de not_active Withdrawn
- 1997-08-04 US US08/905,530 patent/US5948800A/en not_active Expired - Lifetime
- 1997-08-20 AU AU38669/97A patent/AU3866997A/en not_active Abandoned
- 1997-08-20 KR KR1019997001554A patent/KR20000035859A/ko not_active Application Discontinuation
- 1997-08-20 WO PCT/JP1997/002883 patent/WO1998008831A1/ja not_active Application Discontinuation
- 1997-08-21 TW TW086112018A patent/TW501925B/zh not_active IP Right Cessation
- 1997-08-25 CA CA002213794A patent/CA2213794C/en not_active Expired - Fee Related
- 1997-08-26 PL PL97321796A patent/PL188481B1/pl not_active IP Right Cessation
- 1997-08-26 NO NO19973912A patent/NO312812B1/no not_active IP Right Cessation
- 1997-08-26 AU AU35298/97A patent/AU725534B2/en not_active Ceased
- 1997-08-26 ZA ZA977644A patent/ZA977644B/xx unknown
- 1997-08-27 TR TR97/00858A patent/TR199700858A2/xx unknown
-
1998
- 1998-10-22 LV LVP-98-231A patent/LV12251B/lv unknown
- 1998-12-11 FI FI982689A patent/FI119622B/fi not_active IP Right Cessation
-
1999
- 1999-02-23 LT LT99-016A patent/LT4602B/lt not_active IP Right Cessation
- 1999-11-29 HK HK99105534A patent/HK1020317A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI9720060B (en) | Use of 2-phenyl-1, 2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease | |
| CA2012876A1 (en) | Use of 5-methyltetrahydrofolic acid and 5-formyltetrahydrofolic acid in the treatment of organic mental disturbances | |
| AU7068687A (en) | Oxadiazoles useful in the treatment of senile dementia | |
| CA2191101A1 (en) | Materials and methods for treatment of plaquing diseases | |
| NO20002702L (no) | Tienopyrimidiner | |
| DE69017789D1 (de) | 1,2,3,4-Tetrahydro-9-Akridinaminderivate. | |
| CA2019231A1 (en) | Novel acetylcholinesterase inhibitors | |
| WO2002060435A8 (fr) | Cryptotanshinone permettant de prevenir et d'attenuer la maladie d'alzheimer | |
| ATE162076T1 (de) | Verwendung von nadh und nadph zur herstellung eines arzneimittels zur behandlung von morbus alzheimer | |
| AU6001990A (en) | 4-(n-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents | |
| CA2078700A1 (en) | Imidazolylmethyl-pyridines | |
| EP0345247A3 (de) | Verwendung von monosubstituierten selenorganischen Verbindungen zur Herstellung eines Arzneimittels sowie daraus hergestelltes Arzneimittel und Verfahren zu seiner Herstellung | |
| GB9205670D0 (en) | New derivatives of physostigmine,their use and pharmaceutical formulations containing them | |
| ES2008421A6 (es) | Procedimiento para la obtencion de derivados de la pilocarpina. | |
| RU99106244A (ru) | Применение 2-фенил-1,2-бензизоселеназол-3(2h)-она для получения фармацевтического препарата для лечения болезни альцгеймера |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KO00 | Lapse of patent |
Effective date: 20041231 |